Scarica l'app Stockscreener
3.45
19.79%
0.57
Dopo l'orario di chiusura:
3.37
-0.08
-2.32%
Universe Pharmaceuticals Inc Borsa (UPC) Ultime notizie
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Universe Pharmaceuticals stock plunges to 52-week low of $3.20 - Investing.com
Universe Pharmaceuticals stock plunges to 52-week low of $0.08 By Investing.com - Investing.com Australia
Universe Pharmaceuticals stock plunges to 52-week low of $0.08 - Investing.com
Universe Pharmaceuticals Announces Share Consolidation - TipRanks
Universe Pharmaceuticals Plans To Effect Share ConsolidationQuick Facts - Nasdaq
Universe Pharmaceuticals INC Announces Share Consolidation Effective March 24, 2025 - Nasdaq
NewtekOne, Inc. Closes Private Offering of Senior Unsecured Notes - The Manila Times
Universe Pharmaceuticals INC Announces Share Consolidation - GlobeNewswire
Major Shake-up: Universe Pharmaceuticals Announces 40:1 Share ConsolidationWhat It Means For Investors - StockTitan
Universe Pharmaceuticals stock plunges to 52-week low of $0.1 By Investing.com - Investing.com South Africa
Universe Pharmaceuticals stock plunges to 52-week low of $0.1 - Investing.com India
Universe Pharmaceuticals (NYSE:UPC) Trading Down 4.3% – What’s Next? - Defense World
Pre-market Movers: HCTI, HEPA, ZYXI, SYRS ... - RTTNews
Universe Pharmaceuticals Approves Share Consolidation at Extraordinary Meeting - TipRanks
UPC’s price-to-book ratio: An indicator of the company’s performance - US Post News
Universe Pharmaceuticals Adjourns Shareholder Meeting Due to Lack of Quorum - TipRanks
Universe Pharmaceuticals stock plunges to 52-week low of $0.14 - Investing.com India
Universe Pharmaceuticals stock plunges to 52-week low of $0.14 By Investing.com - Investing.com South Africa
Universe Pharmaceuticals receives notice from Nasdaq related to delayed annual report - MSN
Universe Pharmaceuticals faces potential Nasdaq delisting By Investing.com - Investing.com Australia
Universe Pharmaceuticals faces potential Nasdaq delisting - Investing.com India
Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report - The Manila Times
Universe Pharmaceuticals Faces Nasdaq Delisting Risk Due to Delayed Annual Report - TipRanks
Universe Pharmaceuticals INC Faces Potential Delisting from Nasdaq Due to Delinquent Annual Report Filing - Nasdaq
Will Universe Pharmaceuticals Survive Nasdaq's Latest Delisting Threat? - StockTitan
Looking Into Universe Pharmaceuticals's Recent Short Interest - Benzinga
Promising Chinese Stocks Worth Watching – February 21st - Defense World
Dow Tumbles Over 700 Points; US Services PMI Falls In February - Benzinga
Stock market today: Nuburu surged by 81.61% while Aspire Biopharma Holdings plummented by 44.32% in early trading - Business Upturn
Why Five9 Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Universe Pharmaceuticals Adjourns Shareholder Meeting Indefinitely - TipRanks
Universe Pharmaceuticals Adjourns Extraordinary General Meeting Due to Lack of Quorum - TipRanks
Volcon, Inc. and GlucoTrack, Inc. See Massive Gains, While Omega Therapeutics and Universe Pharmaceuticals Struggle - HPBL
5.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):